Details for 2020208218

Up to date per 05.04.2026

Actions

Title / Product Name

HERSTELLUNG VON (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDIN-1-YL)PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020208218

EP Publication Number

3800189

E-Number

1582618

Language

PCT Number

Publication Date

07.04.2021 A

28.06.2023 B1

Registration Date

28.06.2023

AT Publication Date

15.07.2023

Application Date

18.05.2017

Registration Number

Priorities

18.05.2016

201662338359 P

IPC

C07D 487/04 20060101AFI20201203BHEP

Maximum Duration of Protection

18.05.2037

Owner

Loxo Oncology, Inc.281 Tresser Boulevard 9th Floor Stamford, Connecticut 06901US

Array Biopharma, Inc.3200 Walnut Street Boulder, CO 80301US

Representative

Authorized Recipients

Paul CosmoviciGumpendorfer Straße 1421060 WienAT

Inventor

REYNOLDS, MarkLoxo Oncology, Inc. 281 Tresser Blvd. Stamford, CT 06901US

EARY, Charles ToddLoxo Oncology, Inc. 281 Tresser Blvd. Stamford, CT 06901US

SPENCER, Stacey873 Stagecoach Trail Lyons, CO 80540US

JUENGST, Derrick4529 Canterbury Drive Boulder, CO 80301US

HACHE, BrunoLoxo Oncology, Inc. 281 Tresser Blvd. Stamford, CT 06901US

JIANG, YutongArray Biopharma Inc. 3200 Walnut Street Boulder, CO 80301US

HAAS, JuliaArray Biopharma Inc. 3200 Walnut Street Boulder, CO 80301US

ANDREWS, Steven W.Array Biopharma Inc. 3200 Walnut Street Boulder, CO 80301US

Information about Fees